Ulrike Gnad-Vogt | Chief Medical Officer
CureVac AG | Germany

Ulrike Gnad-Vogt, Chief Medical Officer, CureVac AG

Dr. Ulrike Gnad-Vogt is a board certified medical oncologist and hematologist working in the field of cancer immunotherapy since 2005. Before joining CureVac in 2011, she held positions as global medical leader for early cancer immunotherapies at Merck Serono and as attending medical oncologist at National Center for Tumor Diseases in Heidelberg/ Germany. At CureVac Ulrike oversees clinical development and translational research activities for mRNA based cancer vaccines and intratumoral immune modulators.


Oct 29th Day 1 @ 16:15

Next generation mRNA cancer vaccine approaches and intratumoral immunomodulation

last published: 19/Sep/19 13:06 GMT

back to speakers

Sign Up for Event Updates